Frankie Maldonado, the Director of Operations for Life Guard Imaging joins Gayle Guyardo, the host of Bloom, to share more about their innovative CT scan and ...

The NX PET Camera improves what we can see in real-time, built to revolutionize the study of Parkinson's disease ...

LNTH READ THE FULL LNTH RESEARCH REPORT Lantheus Holdings, Inc. (NASDAQ:LNTH) reported first quarter 2025 financial and ...

May 7, 2025Lantheus Holdings, Inc. misses on earnings expectations. Reported EPS is $1.53 EPS, expectations were $1.68. Operator: Good morning. Welcome to the Lantheus First Quarter 2025 Conference ...

The FDA has issued a Complete Response Letter to Telix Pharmaceuticals regarding the NDA for TLX101-CDx for the imaging of gliomas.

LMI will provide Lantheus with a commercial radiodiagnostic Alzheimer’s franchise, a talented team, and NEURACEQ, a globally approved F-18 PET imaging agent used to detect beta-amyloid plaques in ...

Meaningful Fatigue score reduction seen in study is a critically important quality of life (QoL) measure for Multiple Sclerosis patients. All patients experienced stabilization of Expanded Disability ...

Mersede Mokri, founder and CEO of MyoScan AI, was named the second-prize winner, receiving a $1,250 prize from Simon Fraser ...

This review explores the role of PET in imaging immune activation, particularly in oncology. 18F-FDG is widely used for assessing treatment response to immunotherapies and can demonstrate unique ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET[1] imaging agent Illuccix® ...

We are excited to explore a new avenue to treat cancers expressing FAP-α with [ 212 Pb]PSV359," commented Markus Puhlmann, Chief Medical Officer of Perspective. "FAP-α is expressed directly on certain ...

MELBOURNE, Australia, April 29, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET [1] imaging agent ... Annual ...